Question 1

Has Alissa Cooper, MD received payments from drug or device companies?

Accepted Answer

Yes. Drug and device makers reported $2,611,153 in general payments to Alissa Cooper, MD across 801 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Question 2

Does a payment mean Alissa Cooper, MD did something wrong?

Accepted Answer

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Question 3

Where does this information about Alissa Cooper, MD come from?

Accepted Answer

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Company	Payments	Total
AbbVie	629	$1,832,359
Merck	4	$281,468
Daiichi Sankyo Inc.	130	$211,387
F. Hoffmann-la Roche AG	4	$139,541
Amgen	8	$72,179
Genentech, Inc.	6	$35,843
Organon	4	$18,848
Gilead	10	$8,642
AstraZeneca	2	$4,510
Boehringer Ingelheim	2	$3,722
Regeneron Healthcare Solutions, Inc.	2	$2,655

Alissa Cooper, MD

Payments from drug & device makers

Who reported the general payments

How this compares

Medicare billing

Other internal medicine in Boston